Search Results

There are 1659 results for: content related to: Novel targeted therapies in inflammatory breast cancer

  1. Addition of amino acid moieties to lapatinib increases the anti-cancer effect via amino acid transporters

    Biopharmaceutics & Drug Disposition

    Volume 35, Issue 1, January 2014, Pages: 60–69, Han-Joo Maeng, Eun-Seo Kim, Chieyeon Chough, Misuk Joung, Jee Woong Lim, Chang-Koo Shim and Won-Sik Shim

    Version of Record online : 19 NOV 2013, DOI: 10.1002/bdd.1872

  2. You have full text access to this OnlineOpen article
    Activated estrogen receptor-mitogen-activated protein kinases cross talk confer acquired resistance to lapatinib

    Thoracic Cancer

    Volume 6, Issue 6, November 2015, Pages: 695–703, Zhe Li, Sheng-Sheng Yang, Pei-Hao Yin, Tao Chang, Lin-Xiang Shi, Lin Fang and Guo-En Fang

    Version of Record online : 13 FEB 2015, DOI: 10.1111/1759-7714.12239

  3. You have free access to this content
    Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo

    International Journal of Cancer

    Volume 126, Issue 12, 15 June 2010, Pages: 2893–2903, Michael A. Morse, Junping Wei, Zachary Hartman, Wenle Xia, Xiu-Rong Ren, Gangjun Lei, William T. Barry, Takuya Osada, Amy C. Hobeika, Sharon Peplinski, Haixiang Jiang, Gayathri R. Devi, Wei Chen, Neil Spector, Andrea Amalfitano, H. Kim Lyerly and Timothy M. Clay

    Version of Record online : 23 OCT 2009, DOI: 10.1002/ijc.24995

  4. miR-1470 mediates lapatinib induced p27 upregulation by targeting c-jun

    Journal of Cellular Physiology

    Volume 230, Issue 7, July 2015, Pages: 1630–1639, Weiwei Nie, Wei Song, Wenwen Zhang, Yanru Wang, Aiyu Zhu, Jiaqing Shao and Xiaoxiang Guan

    Version of Record online : 27 MAR 2015, DOI: 10.1002/jcp.24910

  5. Positive interaction between lapatinib and capecitabine in human breast cancer models: study of molecular determinants

    Fundamental & Clinical Pharmacology

    Volume 26, Issue 4, August 2012, Pages: 530–537, Mohamed Chefrour, Gérard Milano, Patricia Formento, Sarah Giacometti, Amine Denden, Nicole Renée, Athanassios Iliadis, Jean-Louis Fischel and Joseph Ciccolini

    Version of Record online : 30 MAY 2011, DOI: 10.1111/j.1472-8206.2011.00945.x

  6. Effects of lapatinib and trastuzumab on vascular endothelial growth factor in experimental corneal neovascularization

    Clinical & Experimental Ophthalmology

    Volume 43, Issue 5, July 2015, Pages: 449–457, Mehmet K Kaya, Tamer Demir, Hakan Bulut, Nusret Akpolat and Burak Turgut

    Version of Record online : 24 JUN 2015, DOI: 10.1111/ceo.12500

  7. Quercetin-3-methyl ether inhibits lapatinib-sensitive and -resistant breast cancer cell growth by inducing G2/M arrest and apoptosis

    Molecular Carcinogenesis

    Volume 52, Issue 2, February 2013, Pages: 134–143, Jixia Li, Feng Zhu, Ronald A. Lubet, Antonella De Luca, Clinton Grubbs, Marna E. Ericson, Amelia D'Alessio, Nicola Normanno, Zigang Dong and Ann M. Bode

    Version of Record online : 15 NOV 2011, DOI: 10.1002/mc.21839

  8. Collagen-Coated Lapatinib-Loaded Poly(lactic acid) Microspheres for Breast Cancer in Biomedical Applications

    Advances in Polymer Technology

    Volume 34, Issue 4, Winter 2015, M. N. Prabhakar, Jung-Il Song and K. Chowdoji Rao

    Version of Record online : 26 APR 2015, DOI: 10.1002/adv.21517

  9. You have free access to this content
    Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy

    Hepatology

    Volume 52, Issue 3, September 2010, Pages: 975–986, Zichen Zhang, Regina A. Oyesanya, Deanna J. W. Campbell, Jorge A. Almenara, Jennifer L. DeWitt and Alphonse E. Sirica

    Version of Record online : 20 MAY 2010, DOI: 10.1002/hep.23773

  10. Bioequivalence study with lapatinib powder for oral suspension and the original tablet formulation in cancer patients

    Clinical Pharmacology in Drug Development

    Volume 4, Issue 3, May/June 2015, Pages: 203–209, Kevin M. Koch, Geraldine Ferron-Brady, Colleen Lemmon, Leanne Cartee, Hedy Hollyfield, Anthony M. D'Amelio Jr, Alexandra Piepszak, Ramona F. Swaby, David Curran and Niki Arya

    Version of Record online : 27 OCT 2014, DOI: 10.1002/cpdd.139

  11. Sustained Zero-Order Release of Intact Ultra-Stable Drug-Loaded Liposomes from an Implantable Nanochannel Delivery System

    Advanced Healthcare Materials

    Volume 3, Issue 2, February, 2014, Pages: 230–238, Christian Celia, Silvia Ferrati, Shyam Bansal, Anne L. van de Ven, Barbara Ruozi, Erika Zabre, Sharath Hosali, Donatella Paolino, Maria Grazia Sarpietro, Daniel Fine, Massimo Fresta, Mauro Ferrari and Alessandro Grattoni

    Version of Record online : 23 JUL 2013, DOI: 10.1002/adhm.201300188

  12. Phase II, open-label trial of lapatinib and vinorelbine in women with previously treated HER2-positive metastatic breast cancer

    Asia-Pacific Journal of Clinical Oncology

    Volume 10, Issue 4, December 2014, Pages: 368–375, Arlene Chan, Catherine Shannon, Richard de Boer, Sally Baron-Hay, Andrew Redfern, Astrid Bauwens, Paul Craft, Suzanne Webb, Amanda Townsend and Dusan Kotasek

    Version of Record online : 28 OCT 2014, DOI: 10.1111/ajco.12292

  13. Lapatinib-Induced Liver Injury Characterized by Class II HLA and Gilbert's Syndrome Genotypes

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 4, April 2012, Pages: 647–652, C F Spraggs, L R Parham, C M Hunt and C T Dollery

    Version of Record online : 22 FEB 2012, DOI: 10.1038/clpt.2011.277

  14. You have free access to this content
    Human epidermal growth factor receptor 2 (HER2) extracellular domain levels are associated with progression-free survival in patients with HER2-positive metastatic breast cancer receiving lapatinib monotherapy

    Cancer

    Volume 117, Issue 21, 1 November 2011, Pages: 5013–5020, Allan Lipton, Kim Leitzel, Suhail M. Ali, Walter Carney, Greg Platek, Klaudia Steplewski, Ron Westlund, Robert Gagnon, Anne-Marie Martin and Julie Maltzman

    Version of Record online : 31 MAR 2011, DOI: 10.1002/cncr.26101

  15. You have full text access to this Open Access content
    Antitumor activity of a dual epidermal growth factor receptor and ErbB2 kinase inhibitor MP-412 (AV-412) in mouse xenograft models

    Cancer Science

    Volume 100, Issue 8, August 2009, Pages: 1526–1531, Tsuyoshi Suzuki, Akihiro Fujii, Junichi Ohya, Hideo Nakamura, Fumiko Fujita, Masako Koike and Masahide Fujita

    Version of Record online : 21 APR 2009, DOI: 10.1111/j.1349-7006.2009.01197.x

  16. You have full text access to this Open Access content
    Mechanisms of resistance to anti-human epidermal growth factor receptor 2 agents in breast cancer

    Cancer Science

    Volume 102, Issue 1, January 2011, Pages: 1–8, Toru Mukohara

    Version of Record online : 6 SEP 2010, DOI: 10.1111/j.1349-7006.2010.01711.x

  17. Enzyme- and Transporter-Mediated Drug Interactions with Small Molecule Tyrosine Kinase Inhibitors

    Journal of Pharmaceutical Sciences

    Volume 103, Issue 12, December 2014, Pages: 3810–3833, Jie Shao, John S. Markowitz, Di Bei and Guohua An

    Version of Record online : 10 OCT 2014, DOI: 10.1002/jps.24113

  18. Lapatinib and Ixabepilone for the Treatment of Metastatic Breast Cancer

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 10, October 2008, Pages: 1255–1266, Patti A. Halterman

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.10.1255

  19. You have free access to this content
    A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignancies

    Cancer

    Volume 121, Issue 10, May 15, 2015, Pages: 1645–1653, John F. Deeken, Hongkun Wang, Deepa Subramaniam, Aiwu Ruth He, Jimmy Hwang, John L. Marshall, Christina E. Urso, Yiru Wang, Corinne Ramos, Kenneth Steadman and Michael J. Pishvaian

    Version of Record online : 29 JAN 2015, DOI: 10.1002/cncr.29224

  20. You have free access to this content
    Management of patients with HER2-positive metastatic breast cancer: Is there an optimal sequence of HER2-directed approaches?

    Cancer

    Volume 121, Issue 1, January 1, 2015, Pages: 17–24, Amelia B. Zelnak and Kari B. Wisinski

    Version of Record online : 23 JUL 2014, DOI: 10.1002/cncr.28815